News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,627 Results
Type
Article (47762)
Company Profile (330)
Press Release (694519)
Multimedia
Podcasts (117)
Webinars (18)
Section
Business (209647)
Career Advice (2248)
Deals (36448)
Drug Delivery (124)
Drug Development (82993)
Employer Resources (178)
FDA (16589)
Job Trends (15340)
News (354329)
Policy (33426)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2603)
Accelerated approval (32)
Adcomms (29)
Allergies (139)
Alliances (51128)
ALS (177)
Alzheimer's disease (1691)
Antibody-drug conjugate (ADC) (324)
Approvals (16821)
Artificial intelligence (530)
Autoimmune disease (151)
Automation (37)
Bankruptcy (372)
Best Places to Work (11733)
BIOSECURE Act (21)
Biosimilars (190)
Biotechnology (225)
Bladder cancer (159)
Brain cancer (58)
Breast cancer (639)
Cancer (4870)
Cardiovascular disease (416)
Career advice (1887)
Career pathing (37)
CAR-T (294)
CDC (46)
Celiac Disease (2)
Cell therapy (779)
Cervical cancer (36)
Clinical research (70728)
Collaboration (1768)
Company closure (4)
Compensation (1151)
Complete response letters (62)
COVID-19 (2762)
CRISPR (96)
C-suite (848)
Cystic fibrosis (147)
Data (6230)
Decentralized trials (2)
Denatured (35)
Depression (140)
Diabetes (500)
Diagnostics (6744)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (252)
Drug pricing (195)
Drug shortages (28)
Duchenne muscular dystrophy (233)
Earnings (90980)
Editorial (58)
Employer branding (21)
Employer resources (158)
Events (121203)
Executive appointments (989)
FDA (19706)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1503)
Gene editing (209)
Generative AI (46)
Gene therapy (637)
GLP-1 (1004)
Government (4721)
Grass and pollen (6)
Guidances (384)
Healthcare (19009)
HIV (56)
Huntington's disease (49)
IgA nephropathy (83)
Immunology and inflammation (271)
Immuno-oncology (61)
Indications (104)
Infectious disease (3030)
Inflammatory bowel disease (196)
Inflation Reduction Act (14)
Influenza (113)
Intellectual property (247)
Interviews (360)
IPO (16960)
IRA (51)
Job creations (3942)
Job search strategy (1595)
JPM (65)
Kidney cancer (16)
Labor market (84)
Layoffs (580)
Leadership (36)
Legal (8161)
Liver cancer (91)
Longevity (15)
Lung cancer (645)
Lymphoma (378)
Machine learning (44)
Management (62)
Manufacturing (809)
MASH (165)
Medical device (13801)
Medtech (13853)
Mergers & acquisitions (20550)
Metabolic disorders (1298)
Multiple sclerosis (158)
NASH (18)
Neurodegenerative disease (329)
Neuropsychiatric disorders (92)
Neuroscience (2954)
Neurotech (1)
NextGen: Class of 2026 (6687)
Non-profit (4555)
Now hiring (66)
Obesity (617)
Opinion (303)
Ovarian cancer (165)
Pain (204)
Pancreatic cancer (229)
Parkinson's disease (286)
Partnered (34)
Patents (493)
Patient recruitment (478)
Peanut (56)
People (60569)
Pharmaceutical (68)
Pharmacy benefit managers (29)
Phase 1 (22164)
Phase 2 (31172)
Phase 3 (23092)
Pipeline (5143)
Policy (296)
Postmarket research (2588)
Preclinical (9398)
Press Release (72)
Prostate cancer (236)
Psychedelics (53)
Radiopharmaceuticals (282)
Rare diseases (870)
Real estate (6312)
Recruiting (72)
Regulatory (24960)
Reports (51)
Research institute (2441)
Resumes & cover letters (378)
Rett syndrome (28)
RNA editing (18)
RSV (78)
Schizophrenia (150)
Series A (255)
Series B (196)
Service/supplier (13)
Sickle cell disease (102)
Special edition (24)
Spinal muscular atrophy (159)
Sponsored (42)
Startups (3874)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (89)
The Weekly (80)
Vaccines (1029)
Venture capital (96)
Weight loss (401)
Women's health (87)
Worklife (20)
Date
Last 7 days (606)
Last 30 days (2004)
Last 365 days (30554)
2026 (2900)
2025 (31011)
2024 (36000)
2023 (40706)
2022 (51900)
2021 (56371)
2020 (54692)
2019 (47153)
2018 (35600)
2017 (33139)
2016 (32597)
2015 (38465)
2014 (33847)
2013 (28970)
2012 (29451)
2011 (30120)
2010 (28201)
Location
Africa (819)
Alabama (84)
Alaska (7)
Arizona (308)
Arkansas (13)
Asia (41264)
Australia (6915)
California (11320)
Canada (3270)
China (1130)
Colorado (477)
Connecticut (476)
Delaware (334)
Europe (90201)
Florida (1670)
Georgia (356)
Hawaii (3)
Idaho (61)
Illinois (879)
India (63)
Indiana (519)
Iowa (23)
Japan (425)
Kansas (130)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1392)
Massachusetts (8160)
Michigan (321)
Minnesota (635)
Mississippi (5)
Missouri (126)
Montana (34)
Nebraska (29)
Nevada (122)
New Hampshire (79)
New Jersey (3027)
New Mexico (29)
New York (2988)
North Carolina (1481)
North Dakota (9)
Northern California (5518)
Ohio (330)
Oklahoma (22)
Oregon (41)
Pennsylvania (2279)
Puerto Rico (22)
Rhode Island (47)
South America (1204)
South Carolina (65)
South Dakota (1)
Southern California (4388)
Tennessee (172)
Texas (1740)
United States (40217)
Utah (341)
Vermont (1)
Virginia (260)
Washington D.C. (81)
Washington State (936)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
742,627 Results for "miltenyi biotec inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Verismo Therapeutics Announces Partnership with Miltenyi Biotec to Support Advancing Clinical Programs
September 26, 2025
·
4 min read
Biotech Bay
MiLaboratories and Miltenyi Biotec Announce Strategic Partnership to Advance Next Generation Therapies
MiLaboratories, a leader in RNA immune technologies, and Miltenyi Biotec, a global pioneer in biotechnology, are excited to announce a landmark partnership that promises to revolutionize the field of next-generation therapies.
April 29, 2024
·
3 min read
Press Releases
Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting
December 8, 2025
·
8 min read
Deals
Miltenyi Biotec acquires biosensor company lino Biotech
lino Biotech announced it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023.
March 15, 2023
·
2 min read
Pharm Country
Cell BioEngines Enters Agreement with Miltenyi Bioindustry to Manufacture Hematopoietic Cell Therapy Clinical Program
Cell BioEngines, Inc. announced an agreement with Miltenyi to develop and manufacture its expanded hematopoietic stem cell transplantation product for clinical use in hematology-oncology.
December 29, 2023
·
3 min read
Business
Replay’s oncology-focused product company Syena and Miltenyi Biotec enter into exclusive licensing and GMP manufacturing agreement for PRAME TCR-NK cell therapy based on CliniMACS Prodigy®
Replay today announced a licensing and manufacturing agreement to support the development of a GMP-compliant T-cell receptor (TCR) natural killer (NK) cell therapy targeting the tumor-associated neoantigen, PRAME.
December 18, 2023
·
5 min read
Miltenyi Biotec launches world’s first fully automated light sheet microscope
Miltenyi Biotec today announces the UltraMicroscope Blaze.
August 11, 2020
·
3 min read
Miltenyi Biotec offers automated and closed adherent cell culture solutions on CliniMACS Prodigy®
Miltenyi Biotec announced the immediate availability of its new CliniMACS Prodigy® Adherent Cell Culture System.
August 11, 2020
·
3 min read
Miltenyi Biotec launches new tool for coronavirus-specific T cell research
Miltenyi Biotec today launches the SARS-CoV-2 PepTivator Peptide Pools, a new addition to its popular PepTivator Portfolio specifically developed to help researchers currently investigating COVID-19.
August 11, 2020
·
3 min read
Pharm Country
IsoPlexis Continues Progress on Precision CAR-T cell Characterization with Recent Data Sets & Miltenyi Biotec, Inc. Technology Note
IsoPlexis illustrates progress in CAR-T development & bioprocessing with funding, recent data sets, and co-marketing technology note with Miltenyi Biotec, Inc.
September 26, 2019
·
2 min read
1 of 74,263
Next
